Gregory Downey - Sep 1, 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Financial Officer
Signature
/Gregory Downey/
Stock symbol
LEXX
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
4
Date filed
9/2/2021, 01:19 PM
Previous filing
Jun 9, 2021
Next filing
Aug 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 1.83K Sep 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +10K +40% $0.00 35K Sep 1, 2021 Common Shares 10K $6.23 Direct
holding LEXX Stock Options 4K Sep 1, 2021 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 8K Sep 1, 2021 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 12K Sep 1, 2021 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 17K Sep 1, 2021 Common Shares 5K $5.31 Direct
holding LEXX Stock Options 25K Sep 1, 2021 Common Shares 8K $7.08 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.